When the FLM-HCC group was compared to the non-FLM-HCC group, the non-FLM tumors had a slightly higher proliferative index, with 2.9% of cells demonstrating Ki67 positivity compared to 1.8% in the FLM group. Here, MKI67 is linked to hepatocellular carcinoma.